Aurobindo Pharma Ltd

AUROPHARMA NSE Healthcare Pharmaceuticals
Nifty 200 Nifty 500 Midcap 50 Midcap 100 Midcap 150 LargeMid 250 F&O
₹1,679.80
+0.68%
Delayed · cached 15 min
Fair Value Analysis →

Frequently asked questions

What sector does Aurobindo Pharma Ltd belong to?
Aurobindo Pharma Ltd operates in the Healthcare sector, specifically the Pharmaceuticals industry, and is listed on the NSE.
What is the current share price of AUROPHARMA?
As of the latest available quote, AUROPHARMA traded at ₹1,679.80. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of AUROPHARMA?
Aurobindo Pharma Ltd has a price-to-earnings (P/E) ratio of about 26.22. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of AUROPHARMA?
The market capitalisation of Aurobindo Pharma Ltd is approximately ₹95,116 Cr.
Is Aurobindo Pharma Ltd profitable?
For its latest reported financial year, Aurobindo Pharma Ltd recorded a net profit margin of about 10.41%.
Does AUROPHARMA pay a dividend?
Aurobindo Pharma Ltd does not currently show a dividend yield in our data.
What is the return on equity (ROE) of AUROPHARMA?
Aurobindo Pharma Ltd has a return on equity (ROE) of about 10.10%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of AUROPHARMA?
Over the past 52 weeks, AUROPHARMA has traded between a low of ₹1,066.80 and a high of ₹1,717.00.

These answers are generated from reported financial data and live market figures, for educational and informational purposes only.

Educational data only. Not a recommendation to buy, sell or hold any security.